111 related articles for article (PubMed ID: 30895984)
21. Recent advance of ATP citrate lyase inhibitors for the treatment of cancer and related diseases.
Liang JJ; Zhou XF; Long H; Li CY; Wei J; Yu XQ; Guo ZY; Zhou YQ; Deng ZS
Bioorg Chem; 2024 Jan; 142():106933. PubMed ID: 37890210
[TBL] [Abstract][Full Text] [Related]
22. Discovery and characterization of novel ATP citrate lyase inhibitors from Acanthopanax senticosus (Rupr. & Maxim.) Harms.
Wang P; Guo X; Hou T; Luo F; Li M; Wang X; Zhang J; Wang J; Wang C; Liang X
Fitoterapia; 2024 Jun; 175():105956. PubMed ID: 38604261
[TBL] [Abstract][Full Text] [Related]
23. Identification of lignans as ATP citrate lyase (ACLY) inhibitors from the roots of
Li JL; Jiang JY; Gu SS; Zhang L; Sun Y; Wang XH; Li DY; Chen ZY; Jiang SS; Zhu WZ; Jiang HW; Zhang HJ
Nat Prod Res; 2024 May; 38(10):1719-1726. PubMed ID: 37265118
[TBL] [Abstract][Full Text] [Related]
24. Selective inhibition of p97 by chlorinated analogues of dehydrocurvularin.
Tillotson J; Bashyal BP; Kang M; Shi T; De La Cruz F; Gunatilaka AA; Chapman E
Org Biomol Chem; 2016 Jul; 14(25):5918-21. PubMed ID: 27223265
[TBL] [Abstract][Full Text] [Related]
25. ATP-citrate lyase: a mini-review.
Chypre M; Zaidi N; Smans K
Biochem Biophys Res Commun; 2012 May; 422(1):1-4. PubMed ID: 22575446
[TBL] [Abstract][Full Text] [Related]
26. ATP-citrate lyase as a target for hypolipidemic intervention. Sulfoximine and 3-hydroxy-beta-lactam containing analogues of citric acid as potential tight-binding inhibitors.
Dolle RE; McNair D; Hughes MJ; Kruse LI; Eggelston D; Saxty BA; Wells TN; Groot PH
J Med Chem; 1992 Dec; 35(26):4875-84. PubMed ID: 1479587
[TBL] [Abstract][Full Text] [Related]
27. ACLY inhibitors induce apoptosis and potentiate cytotoxic effects of sorafenib in thyroid cancer cells.
Huang SS; Tsai CH; Kuo CY; Li YS; Cheng SP
Endocrine; 2022 Oct; 78(1):85-94. PubMed ID: 35761130
[TBL] [Abstract][Full Text] [Related]
28. ATP-citrate lyase regulates cellular senescence via an AMPK- and p53-dependent pathway.
Lee JH; Jang H; Lee SM; Lee JE; Choi J; Kim TW; Cho EJ; Youn HD
FEBS J; 2015 Jan; 282(2):361-71. PubMed ID: 25367309
[TBL] [Abstract][Full Text] [Related]
29. Synthesis of novel thiol-containing citric acid analogues. Kinetic evaluation of these and other potential active-site-directed and mechanism-based inhibitors of ATP citrate lyase.
Dolle RE; Gribble A; Wilkes T; Kruse LI; Eggleston D; Saxty BA; Wells TN; Groot PH
J Med Chem; 1995 Feb; 38(3):537-43. PubMed ID: 7853346
[TBL] [Abstract][Full Text] [Related]
30. Prevention of Diet-Induced Metabolic Dysregulation, Inflammation, and Atherosclerosis in
Samsoondar JP; Burke AC; Sutherland BG; Telford DE; Sawyez CG; Edwards JY; Pinkosky SL; Newton RS; Huff MW
Arterioscler Thromb Vasc Biol; 2017 Apr; 37(4):647-656. PubMed ID: 28153881
[TBL] [Abstract][Full Text] [Related]
31. ATP citrate lyase inhibition can suppress tumor cell growth.
Hatzivassiliou G; Zhao F; Bauer DE; Andreadis C; Shaw AN; Dhanak D; Hingorani SR; Tuveson DA; Thompson CB
Cancer Cell; 2005 Oct; 8(4):311-21. PubMed ID: 16226706
[TBL] [Abstract][Full Text] [Related]
32. ATP-citrate lyase: a key player in cancer metabolism.
Zaidi N; Swinnen JV; Smans K
Cancer Res; 2012 Aug; 72(15):3709-14. PubMed ID: 22787121
[TBL] [Abstract][Full Text] [Related]
33. Prognostic impact of the combination of glucose transporter 1 and ATP citrate lyase in node-negative patients with non-small lung cancer.
Osugi J; Yamaura T; Muto S; Okabe N; Matsumura Y; Hoshino M; Higuchi M; Suzuki H; Gotoh M
Lung Cancer; 2015 Jun; 88(3):310-8. PubMed ID: 25837797
[TBL] [Abstract][Full Text] [Related]
34. Polyamine regulating protein antizyme binds to ATP citrate lyase to accelerate acetyl-CoA production in cancer cells.
Tajima A; Murai N; Murakami Y; Iwamoto T; Migita T; Matsufuji S
Biochem Biophys Res Commun; 2016 Mar; 471(4):646-51. PubMed ID: 26915799
[TBL] [Abstract][Full Text] [Related]
35. ATP-Citrate lyase as a target for hypolipidemic intervention. 2. Synthesis and evaluation of (3R,5S)-omega-substituted-3-carboxy-3, 5-dihydroxyalkanoic acids and their gamma-lactone prodrugs as inhibitors of the enzyme in vitro and in vivo.
Gribble AD; Ife RJ; Shaw A; McNair D; Novelli CE; Bakewell S; Shah VP; Dolle RE; Groot PH; Pearce N; Yates J; Tew D; Boyd H; Ashman S; Eggleston DS; Haltiwanger RC; Okafo G
J Med Chem; 1998 Sep; 41(19):3582-95. PubMed ID: 9733484
[TBL] [Abstract][Full Text] [Related]
36. Metabolic Routes in Inflammation: The Citrate Pathway and its Potential as Therapeutic Target.
Infantino V; Pierri CL; Iacobazzi V
Curr Med Chem; 2019; 26(40):7104-7116. PubMed ID: 29745322
[TBL] [Abstract][Full Text] [Related]
37. ATP-Citrate Lyase Controls a Glucose-to-Acetate Metabolic Switch.
Zhao S; Torres A; Henry RA; Trefely S; Wallace M; Lee JV; Carrer A; Sengupta A; Campbell SL; Kuo YM; Frey AJ; Meurs N; Viola JM; Blair IA; Weljie AM; Metallo CM; Snyder NW; Andrews AJ; Wellen KE
Cell Rep; 2016 Oct; 17(4):1037-1052. PubMed ID: 27760311
[TBL] [Abstract][Full Text] [Related]
38. miR-133b acts as a tumor suppressor and negatively regulates ATP citrate lyase via PPARÎł in gastric cancer.
Cheng Y; Jia B; Wang Y; Wan S
Oncol Rep; 2017 Nov; 38(5):3220-3226. PubMed ID: 28901466
[TBL] [Abstract][Full Text] [Related]
39. Discovery and characterization of novel ATP citrate lyase inhibitors from natural products by a luminescence-based assay.
Wang P; Peng X; Hou T; Xu F; Zhou H; Yu Y; Qiu M; Liu Y; Zhao Y; Guo Z; Wang J; Liang X
Chem Biol Interact; 2022 Nov; 367():110199. PubMed ID: 36174740
[TBL] [Abstract][Full Text] [Related]
40. The lipogenesis pathway as a cancer target.
Abramson HN
J Med Chem; 2011 Aug; 54(16):5615-38. PubMed ID: 21726077
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
